ABCG2-IN-4 (Compound K31) is an orally active inhibitor for ABCG2 , which reduces the release of Protoporphyrin IX (PPIX) from erythrocytes into plasma, and prevents the reduces phototoxicity. ABCG2-IN-4 exhibits anti-inflammatory and antioxidant activity in mouse models.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.